NL7511089A - Immunologische verbindingen. - Google Patents

Immunologische verbindingen.

Info

Publication number: NL7511089A
Authority: NL; Netherlands
Prior art keywords: immunological; connections; immunological connections
Prior art date: 1974-09-20

Application number

NL7511089A

Other languages

English (en)

Original Assignee

Searle & Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1974-09-20

Filing date

1975-09-19

Publication date

1976-03-23

1975-09-19 Application filed by Searle & Co filed Critical Searle & Co

1976-03-23 Publication of NL7511089A publication Critical patent/NL7511089A/nl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6889—Conjugates wherein the antibody being the modifying agent and wherein the linker, binder or spacer confers particular properties to the conjugates, e.g. peptidic enzyme-labile linkers or acid-labile linkers, providing for an acid-labile immuno conjugate wherein the drug may be released from its antibody conjugated part in an acidic, e.g. tumoural or environment

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Immunology (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Metal Rolling (AREA)

NL7511089A 1974-09-20 1975-09-19 Immunologische verbindingen. NL7511089A (nl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB41037/74A GB1509707A (en)	1974-09-20	1974-09-20	Immunological compounds

Publications (1)

Publication Number	Publication Date
NL7511089A true NL7511089A (nl)	1976-03-23

Family

ID=10417824

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NL7511089A NL7511089A (nl)	1974-09-20	1975-09-19	Immunologische verbindingen.

Country Status (7)

Country	Link
JP (1)	JPS5161640A (nl)
DE (1)	DE2541931A1 (nl)
DK (1)	DK141773B (nl)
FR (1)	FR2285145A1 (nl)
GB (1)	GB1509707A (nl)
NL (1)	NL7511089A (nl)
SE (1)	SE7510505L (nl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4067971A (en) *	1976-05-13	1978-01-10	The Procter & Gamble Company	Therapeutic composition
JPS54132503A (en) *	1978-04-07	1979-10-15	Kayaku Antibiotic Research Co	Immune globulin combined neocarcinostatin
JPS5665829A (en) *	1979-11-02	1981-06-03	Kureha Chem Ind Co Ltd	Antitumor agent
JPS5592325A (en) *	1978-12-29	1980-07-12	Kureha Chem Ind Co Ltd	Antitumor agent and its preparation
US4315851A (en)	1978-12-29	1982-02-16	Kureha Kagaku Kogyo Kabushiki Kaisha	Pharmaceutical composition having antitumor activity
JPS5665828A (en) *	1979-11-02	1981-06-03	Kureha Chem Ind Co Ltd	Antitumor agent
EP0037388B1 (fr) *	1980-03-31	1984-12-12	Institut International De Pathologie Cellulaire Et Moleculaire	Formes pharmaceutiques, leur préparation et les compositions qui les contiennent
JPS58118520A (ja) *	1982-01-09	1983-07-14	Hidematsu Hirai	抗腫瘍性蛋白複合体およびその製造法
JPS59186924A (ja) *	1983-04-08	1984-10-23	Kureha Chem Ind Co Ltd	ヒト免疫グロブリン結合抗腫瘍剤
GB2148299B (en) *	1983-09-01	1988-01-06	Hybritech Inc	Antibody compositions of therapeutic agents having an extended serum half-life
DE3513572A1 (de) *	1985-04-16	1986-10-16	Karl Prof. Dr.med. 7302 Ostfildern Theurer	Herstellung von praeparaten zur spezifischen beeinflussung der humoralen und zellulaeren immunreaktion
JPS62228025A (ja) *	1985-12-27	1987-10-06	Teijin Ltd	抗体複合体の製造方法
WO1988007553A1 (en) *	1987-03-26	1988-10-06	Teijin Limited	Process for preparing antibody complex
US5773435A (en) *	1987-08-04	1998-06-30	Bristol-Myers Squibb Company	Prodrugs for β-lactamase and uses thereof
AU649275B2 (en) *	1990-11-06	1994-05-19	Bristol-Myers Squibb Company	Prodrugs for beta-lactamase and uses thereof
DE4122210C2 (de) *	1991-07-04	1999-04-01	Deutsches Krebsforsch	Konjugate aus tumoraktiver Verbindung und Serumalbumin sowie Verfahren zu deren Herstellung und ihre Verwendung

1974
- 1974-09-20 GB GB41037/74A patent/GB1509707A/en not_active Expired
1975
- 1975-09-19 DE DE19752541931 patent/DE2541931A1/de not_active Withdrawn
- 1975-09-19 DK DK422475AA patent/DK141773B/da unknown
- 1975-09-19 NL NL7511089A patent/NL7511089A/nl not_active Application Discontinuation
- 1975-09-19 FR FR7528837A patent/FR2285145A1/fr active Granted
- 1975-09-19 SE SE7510505A patent/SE7510505L/xx unknown
- 1975-09-19 JP JP50113541A patent/JPS5161640A/ja active Pending

Also Published As

Publication number	Publication date
DK141773B (da)	1980-06-16
SE7510505L (sv)	1976-03-22
DE2541931A1 (de)	1976-04-01
FR2285145A1 (fr)	1976-04-16
DK141773C (nl)	1980-11-03
FR2285145B1 (nl)	1980-05-30
JPS5161640A (en)	1976-05-28
GB1509707A (en)	1978-05-04
DK422475A (nl)	1976-03-21

Publication	Publication Date	Title
NL7510505A (nl)	1976-03-09	Tetracyclische verbindingen.
SE7500929L (sv)	1975-12-15	Munoppenhallare.
SE413001B (sv)	1980-03-31	Strenggjutningsanleggning.
NL7511089A (nl)	1976-03-23	Immunologische verbindingen.
NO143759C (no)	1981-04-08	Sjoeplattformanordning.
NL7504306A (nl)	1975-10-14	Halfgeleider-schakeling.
SE7503535L (sv)	1975-09-29	Streptomycetalt amtibiotikum.
SE7508358L (sv)	1976-01-30	Gymnastikapparat.
NO149010C (no)	1984-01-25	Kompressor.
DK135492B (da)	1977-05-09	Lastpalle.
SE7409757L (sv)	1976-01-30	Presstativ.
SE7508546L (sv)	1976-02-13	Reliefbokstever.
NO141322C (no)	1980-02-13	Noed-doeraapner.
NL7503268A (nl)	1975-09-29	Cyclische verbindingen.
NO138352C (no)	1978-08-23	Ystetank.
SE7507132L (sv)	1975-12-22	Hogtalargaller.
NL7505400A (nl)	1975-11-11	Bicyclische verbindingen.
DK137669B (da)	1978-04-17	Piberiver.
BE809593A (fr)	1974-05-02	Groupe-moteur-autopropulseur.
NL7500945A (nl)	1975-07-31	Mollenval.
NL7416085A (nl)	1976-06-14	Heiblok.
BE814204A (nl)	1974-08-16	Werkkledij.
NL7503137A (nl)	1975-09-23	Tricyclische verbindingen.
SE7503576L (sv)	1975-09-29	Metallhalidkomplex.
NO139660C (no)	1979-04-25	Sileringshjelpemiddel.

Legal Events

Date	Code	Title	Description
1982-05-03	BV	The patent application has lapsed